Page 42 - Multiple Sclerosis News Today

GLP-1 therapy was well tolerated among patients with multiple sclerosis and obesity, with an average weight loss of 12 lb.

MMJ BioPharma Cultivation Sues the DEA once again - Is the DEA a Rogue ...

The DEA Games Continue To Delay Legitimate Marijuana Clinical Trials and ResearchWASHINGTON, DC / ACCESSWIRE / April 4, 2024 / Megan Sheehan and Associates, lawyers representing MMJ BioPharma Cultivation, is filing an interlocutory appeal in Federal Court this week contesting a DEA administrative law judicial hearin...

A team of researchers from the Case Western Reserve University School of Medicine has provided fresh insight into the dangers some common household chemicals pose to brain health. They suggest tha ...

The pianist Alice Sara Ott, who makes her New York Philharmonic debut this week, is upending concert culture — and defying stereotypes about multiple sclerosis.

Delphia Brown (left) exercises at the Stephen A. Orthwein Center, a wheelchair-accessible gym in St. Louis operated by Paraquad, an organization that helps people with disabilities achieve independence.

Merrill G. Hale

Children who are obese may be at higher risk of being diagnosed with multiple sclerosis (MS) in early adulthood, a new study suggests. The risk of being...

GLP-1 therapy was well tolerated among patients with multiple sclerosis and obesity, with an average weight loss of 12 lb.

Dear Editor, There is a special provision in the Narcotics and Misuse of Drugs Act 2004, number 33, that allows you to grow as many marijuana plants as you want, as long as you don’t use it for a pharmacological effect.